Detectable HIV-1 in semen in individuals with very low blood viral loads.
Blood
HIV-1
Semen
Viral load
Journal
Virology journal
ISSN: 1743-422X
Titre abrégé: Virol J
Pays: England
ID NLM: 101231645
Informations de publication
Date de publication:
05 03 2020
05 03 2020
Historique:
received:
12
12
2019
accepted:
20
02
2020
entrez:
7
3
2020
pubmed:
7
3
2020
medline:
11
2
2021
Statut:
epublish
Résumé
Several reports indicate that a portion (5-10%) of men living with HIV-1 intermittently shed HIV-1 RNA into seminal plasma while on long term effective antiretroviral therapy (ART). This is highly suggestive of an HIV-1 reservoir in the male genital tract. However, the status of this reservoir in men living with HIV-1 who are not under treatment is underexplored and has implications for understanding the origins and evolution of the reservoir. Forty-three HIV-1 positive, antiretroviral therapy naïve study participants attending a men's health clinic were studied. Semen viral loads and blood viral loads were generally correlated, with semen viral loads generally detected in individuals with blood viral loads > 10,000 cp/ml. However, we found 1 individual with undetectable viral loads (<20cp/ml) and 2 individuals with very low blood viral load (97 and 333cp/ml), but with detectable HIV-1 in semen (485-1157 copies/semen sample). Blood viral loads in the first individual were undetectable when tested three times over the prior 5 years. Semen HIV-1 viral loads are usually related to blood viral loads, as we confirm. Nonetheless, this was not true in a substantial minority of individuals suggesting unexpectedly high levels of replication in the male genital tract in a few individuals, despite otherwise effective immune control. This may reflect establishment of a local reservoir of HIV-1 populations.
Sections du résumé
BACKGROUND
Several reports indicate that a portion (5-10%) of men living with HIV-1 intermittently shed HIV-1 RNA into seminal plasma while on long term effective antiretroviral therapy (ART). This is highly suggestive of an HIV-1 reservoir in the male genital tract. However, the status of this reservoir in men living with HIV-1 who are not under treatment is underexplored and has implications for understanding the origins and evolution of the reservoir.
FINDING
Forty-three HIV-1 positive, antiretroviral therapy naïve study participants attending a men's health clinic were studied. Semen viral loads and blood viral loads were generally correlated, with semen viral loads generally detected in individuals with blood viral loads > 10,000 cp/ml. However, we found 1 individual with undetectable viral loads (<20cp/ml) and 2 individuals with very low blood viral load (97 and 333cp/ml), but with detectable HIV-1 in semen (485-1157 copies/semen sample). Blood viral loads in the first individual were undetectable when tested three times over the prior 5 years.
CONCLUSIONS
Semen HIV-1 viral loads are usually related to blood viral loads, as we confirm. Nonetheless, this was not true in a substantial minority of individuals suggesting unexpectedly high levels of replication in the male genital tract in a few individuals, despite otherwise effective immune control. This may reflect establishment of a local reservoir of HIV-1 populations.
Identifiants
pubmed: 32138741
doi: 10.1186/s12985-020-01300-6
pii: 10.1186/s12985-020-01300-6
pmc: PMC7059658
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
29Références
J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):275-81
pubmed: 23274933
Lancet. 2019 Jun 15;393(10189):2428-2438
pubmed: 31056293
Clin Infect Dis. 2014 Jun;58(12):1763-70
pubmed: 24647014
Clin Infect Dis. 2019 Oct 30;69(10):1789-1796
pubmed: 30615106
AIDS. 1996 Dec;10(14):F51-6
pubmed: 8970677
Nat Microbiol. 2019 Apr;4(4):633-644
pubmed: 30718846
J Virol. 2015 May;89(10):5264-75
pubmed: 25673728
Cell. 2013 Oct 24;155(3):540-51
pubmed: 24243014
S Afr Med J. 2017 Nov 27;107(12):1116-1120
pubmed: 29262967
J Reprod Immunol. 1998 Dec;41(1-2):27-40
pubmed: 10213299
AIDS. 1999 Jul 30;13(11):1415-7
pubmed: 10449298
Sex Transm Dis. 2008 Jan;35(1):55-60
pubmed: 18217225
JAMA. 2019 Feb 5;321(5):451-452
pubmed: 30629090
AIDS. 2012 May 15;26(8):971-5
pubmed: 22382146
J Infect Dis. 2016 Jul 15;214(2):212-5
pubmed: 27053765
AIDS. 1999 May 7;13(7):823-31
pubmed: 10357382
J Infect Dis. 2014 Apr 15;209(8):1174-84
pubmed: 24273175
J Antimicrob Chemother. 2016 Nov;71(11):3202-3205
pubmed: 27432601
PLoS Pathog. 2018 Jan 18;14(1):e1006754
pubmed: 29346424
J Infect Dis. 2000 May;181(5):1622-8
pubmed: 10783117
Sex Transm Infect. 1999 Aug;75(4):261-3
pubmed: 10615314
Curr Opin HIV AIDS. 2018 Sep;13(5):395-401
pubmed: 29847350
PLoS One. 2017 Aug 16;12(8):e0183376
pubmed: 28813503
Nat Rev Microbiol. 2015 Jul;13(7):414-25
pubmed: 26052661
J Virol. 1997 Aug;71(8):6271-5
pubmed: 9223532
Curr Opin HIV AIDS. 2010 Jul;5(4):335-43
pubmed: 20543610
J Clin Microbiol. 2000 Apr;38(4):1414-8
pubmed: 10747117
Clin Infect Dis. 2013 Aug;57(3):441-7
pubmed: 23595831
Retrovirology. 2017 Mar 23;14(1):22
pubmed: 28335782